An Appraisal of the Potential Downstream Benefits of RSV Vaccination in Older Adults. [PDF]
Rzymski P.
europepmc +1 more source
The Impact of Respiratory Syncytial Virus Undertesting on Estimates of Disease Burden and Vaccine Effectiveness in a Large Integrated Healthcare System. [PDF]
Ackerson BK +24 more
europepmc +1 more source
Hospital Admissions for Respiratory Syncytial Virus (RSV) Among Elderly: A Retrospective Study From an Italian Southern Region During Years 2018-2023. [PDF]
Di Martino G +9 more
europepmc +1 more source
Respiratory Syncytial Virus Hospitalizations in Adults ≥50 Years of Age and Those With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Exacerbations, 2018-2020. [PDF]
Tippett A +33 more
europepmc +1 more source
Construction and application of a novel respiratory syncytial virus vaccine based on <i>Bacteroides thetaiotaomicron</i> outer membrane vesicles. [PDF]
Li X +10 more
europepmc +1 more source
Mutational constraints on RSV F and its neutralization by antibodies. [PDF]
Simonich CAL +5 more
europepmc +1 more source
Early impact of maternal RSV vaccination on bronchiolitis hospitalisation and critical care admissions in infants under age 3 months, England, September 2024 to March 2026. [PDF]
Broad J +7 more
europepmc +1 more source
Respiratory Syncytial Virus Vaccination as Cardiopulmonary and Cardiovascular Risk Mitigation in Adults with Heart Disease. [PDF]
Bonanad C +12 more
europepmc +1 more source
Arp2/3 complex-dependent actin remodeling is required for efficient RSV uncoating in A549 cells. [PDF]
Xie E +10 more
europepmc +1 more source

